Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (282)	9/25/2000 4:00:18 PM
From: BulbaMan	Read Replies (1) \| Respond to of 1833

Rick: Please don't take my (sic) personally. As a former editor, it's hard to resist (sic)ing people. As for phoning Glass, in the past couple of years it's become my general rule not to call company management since I discovered talking to these guys tends to influence my investment decisions for the worse – maybe I'm just too trusting when I actually speak to a person as opposed to reading a company's filings. So, no, I haven't ever called Cadus but am hoping someone else will and report to the board (and I can selfishly benefit). As for your phone bill, I'm not completely selfish, so I'll magnanimously reimburse you for the call – up to $1.00, ok, make it $1.25. (I assume Glass can be reached through the Cadus number: 212-702-4315.) OT: Do you follow SMDX? Amazingly, their market-cap is even less than that of KDUS. (I posted today's SMDX press release on the BFLTAB board.) And, yes, I always agree with you! <G>